Enzymes sequestered

Neutrophils represent an ideal system for studying osmotic effects on exocytosis. Stimulation of cytochalasin-B-treated neutrophils with the chemotactic peptide Jlf-formylmethionyl-leucyl-phenyl-alanine (FMLP) results in a rapid compound exocytosis up to 80% of lysosomal enzymes are released within 30 s (9-14). Secretion appears to be triggered by a rise in the level of cytosolic free calcium (15-18) promoted in part by entry of extracellular calcium through receptor-gated channels and in part by release of calcium that is sequestered or bound at some intracellular site (19-21). In this presentation, we augment our previously published data (22,23), which demonstrates that lysosomal enzyme release from neutrophils is inhibited under hyperosmotic conditions and that the rise in cytosolic calcium preceding secretion is inhibited as well. 

In all the treatments of enzyme-inhibitor interactions that we have discussed so far, we assumed that the inhibitor concentration required to achieve 50% inhibition is far in excess of the concentration of enzyme in the reaction mixture. The concentration of inhibitor that is sequestered in formation of the El complex is therefore a very small fraction of the total inhibitor concentration added to the reaction. Hence one may ignore this minor perturbation and safely assume that the concentration of free inhibitor is well approximated by the total concentration of inhibitor (i.e, [7]f [/]T). This is a typical assumption that holds for most protein-ligand binding interactions, as discussed in Copeland (2000) and in Appendix 2. 

The partitioning of the activated inhibitor between direct covalent inactivation of the enzyme and release into solution is an important issue for mechanism-based inactivators. The partition ratio is of value as a quantitative measure of inactivation efficiency, as described above. This value is also important in assessing the suitability of a compound as a drug for clinical use. If the partition ratio is high, this means that a significant proportion of the activated inhibitor molecules is not sequestered as a covalent adduct with the target enzyme but instead is released into solution. Once released, the compound can diffuse away to covalently modify other proteins within the cell, tissue, or systemic circulation. This could then lead to the same types of potential clinical liabilities that were discussed earlier in this chapter in the context of affinity labels, and would therefore erode the potential therapeutic index for such a compound. 

Phytostabilization in the root cells. Proteins and enzymes present on the root cell walls can facilitate the transport of contaminants across the root membranes. Upon uptake, these contaminants can be sequestered into the vacuole of the root cells, preventing further translocation to the shoots. 

Several enzymes have been immobilized in sol-gel matrices effectively and employed in diverse applications. Urease, catalase, and adenylic acid deaminase were first encapsulated in sol-gel matrices [72], The encapsulated urease and catalase retained partial activity but adenylic acid deaminase completely lost its activity. After three decades considerable attention has been paid again towards the bioencapsulation using sol-gel glasses. Braun et al. [73] successfully encapsulated alkaline phosphatase in silica gel, which retained its activity up to 2 months (30% of initial) with improved thermal stability. Further Shtelzer et al. [58] sequestered trypsin within a binary sol-gel-derived composite using TEOS and PEG. Ellerby et al. [74] entrapped other proteins such as cytochrome c and Mb in TEOS sol-gel. Later several proteins such as Mb [8], hemoglobin (Hb) [56], cyt c [55, 75], bacteriorhodopsin (bR) [76], lactate oxidase [77], alkaline phosphatase (AP) [78], GOD [51], HRP [79], urease [80], superoxide dismutase [8], tyrosinase [81], acetylcholinesterase [82], etc. have been immobilized into different sol-gel matrices. Hitherto some reports have described the various aspects of sol-gel entrapped biomolecules such as conformation [50, 60], dynamics [12, 83], accessibility [46], reaction kinetics [50, 54], activity [7, 84], and stability [1, 80],... 

Extracellular enzymes are rapidly sorbed at mineral and humic colloids in soils and sediments. Mineral colloids have a high affinity for enzymes although that is not always synonymous with the retention of their catalytic ability. On the other hand, humic substances have the ability to sorb and sequester enzymes in such a way as to retain their catalytic activity they could also strongly inactivate enzyme activity depending on interaction mechanisms. 

Based on the three-dimensional structure of CHS, we proposed that the initiation/elongation/cyclization cavity serves as a structural template that selectively stabilizes a particular folded conformation of the linear tetraketide, allowing the Claisen condensation to proceed from C6 to Cl of the reaction intermediate.14 In contrast, CTAL formation can occur either in solution or alternatively while sequestered in the enzyme active site. In either case, enolization of the C5 ketone followed by nucleophilic attack on the Cl ketone with either a hydroxyl group (in solution) or the cysteine thiolate (enzyme bound) as the leaving group results in CTAL. Similar lactones are commonly formed as by-products of in vitro reactions in other PKS systems.36 38... 

DG). InsP3, as we saw above, stimulates the release of Ca2+, sequestered in the ER, and this in turn activates numerous cellular processes through Ca2+-binding proteins, such as calmodulin. The membrane-associated DG activates protein kinase C to phosphorylate and activate other enzymes, such as glycogen phosphorylase. This step also requires Ca2+. 

Enzyme labels are usually associated with solid-phase antibodies in the technique known as enzyme-linked immunosorbent assay (ELISA). There are several variants of this technique employing both competitive and non-competitive systems. However it is best used in combination with two monoclonal antibodies in the two-site format in which an excess of antibody is bound to a solid phase such as a test-tube or microtitre plate the test antigen is then added and is largely sequestered by the antibody (Figure 7.12). After washing... 

The devices usually contain antibody immobilized on a membrane surface above a filter and absorbent pad (Figure 7.16). The sample is placed in the device and passes through the membrane into the absorbent pad. Where analyte is present in the sample it is sequestered by the antibody on the membrane and is then visualized by addition of a labelled second antibody. Labelled second antibody not bound to analyte also passes into the absorbent pad, sometimes with the aid of a wash solution. The labelled molecule may be an enzyme, which would then require addition of a suitable substrate, or a label such as colloidal gold, which has the virtue of being visible without the aid of a second reagent. 

---